欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2280/001
药品名称
Movevit
活性成分
Mesalazine 500.0 mg
剂型
Suppository
上市许可持有人
Laboratórios Vitória, S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Denmark (DK)
Sweden (SE)
Norway (NO)
Mesalazin Orion
Finland (FI)
Cyprus (CY)
Mecolzine 500mg suppositories
Malta (MT)
许可日期
2020/01/29
最近更新日期
2025/01/24
药物ATC编码
A ALIMENTARY TRACT AND METABOLISM
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
1_3_1 common_outer_500mg
Date of last change:2024/09/06
Final Product Information
|
1_3_1 common_pl_500mg
Date of last change:2024/09/06
Final Product Information
|
1_3_1 common_spc_500mg
Date of last change:2024/09/06
PubAR
|
2280_Movevit_PAR_3FEV2020
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase